Literature DB >> 29125368

Societal burden of cluster headache in the United States: a descriptive economic analysis.

Janet H Ford1, Damion Nero2, Gilwan Kim2, Bong Chul Chu2, Robert Fowler2, Jonna Ahl1, James M Martinez1.   

Abstract

AIM: To estimate direct and indirect costs in patients with a diagnosis of cluster headache in the US.
METHODS: Adult patients (18-64 years of age) enrolled in the Marketscan Commercial and Medicare Databases with ≥2 non-diagnostic outpatient (≥30 days apart between the two outpatient claims) or ≥1 inpatient diagnoses of cluster headache (ICD-9-CM code 339.00, 339.01, or 339.02) between January 1, 2009 and June 30, 2014, were included in the analyses. Patients had ≥6 months of continuous enrollment with medical and pharmacy coverage before and after the index date (first cluster headache diagnosis). Three outcomes were evaluated: (1) healthcare resource utilization, (2) direct healthcare costs, and (3) indirect costs associated with work days lost due to absenteeism and short-term disability. Direct costs included costs of all-cause and cluster headache-related outpatient, inpatient hospitalization, surgery, and pharmacy claims. Indirect costs were based on an average daily wage, which was estimated from the 2014 US Bureau of Labor Statistics and inflated to 2015 dollars.
RESULTS: There were 9,328 patients with cluster headache claims included in the analysis. Cluster headache-related total direct costs (mean [standard deviation]) were $3,132 [$13,396] per patient per year (PPPY), accounting for 17.8% of the all-cause total direct cost. Cluster headache-related inpatient hospitalizations ($1,604) and pharmacy ($809) together ($2,413) contributed over 75% of the cluster headache-related direct healthcare cost. There were three sub-groups of patients with claims associated with indirect costs that included absenteeism, short-term disability, and absenteeism + short-term disability. Indirect costs PPPY were $4,928 [$4,860] for absenteeism, $803 [$2,621] for short-term disability, and $3,374 [$3,198] for absenteeism + disability.
CONCLUSION: Patients with cluster headache have high healthcare costs that are associated with inpatient admissions and pharmacy fulfillments, and high indirect costs associated with absenteeism and short-term disability.

Entities:  

Keywords:  Direct and indirect cost analysis; absenteeism; claims; cluster headache; healthcare resource utilization; short-term disability

Mesh:

Year:  2017        PMID: 29125368     DOI: 10.1080/13696998.2017.1404470

Source DB:  PubMed          Journal:  J Med Econ        ISSN: 1369-6998            Impact factor:   2.448


  7 in total

1.  'A cry in the dark': a qualitative exploration of living with cluster headache.

Authors:  Laura Andre; Debbie Cavers
Journal:  Br J Pain       Date:  2020-12-02

2.  Impact of cluster headache on employment status and job burden: a prospective cross-sectional multicenter study.

Authors:  Yun-Ju Choi; Byung-Kun Kim; Pil-Wook Chung; Mi Ji Lee; Jung-Wook Park; Min Kyung Chu; Jin-Young Ahn; Byung-Su Kim; Tae-Jin Song; Jong-Hee Sohn; Kyungmi Oh; Kwang-Soo Lee; Soo-Kyoung Kim; Kwang-Yeol Park; Jae Myun Chung; Heui-Soo Moon; Chin-Sang Chung; Soo-Jin Cho
Journal:  J Headache Pain       Date:  2018-09-03       Impact factor: 7.277

3.  Direct and indirect costs of cluster headache: a prospective analysis in a tertiary level headache centre.

Authors:  Andrea Negro; Paolo Sciattella; Valerio Spuntarelli; Paolo Martelletti; Francesco Saverio Mennini
Journal:  J Headache Pain       Date:  2020-05-04       Impact factor: 7.277

4.  Cluster Headache and the Comprehension Paradox.

Authors:  Heiko Pohl; Andreas R Gantenbein; Peter S Sandor; Jean Schoenen; Colette Andrée
Journal:  SN Compr Clin Med       Date:  2022-01-10

5.  Phenotype of Cluster Headache: Clinical Variability, Persisting Pain Between Attacks, and Comorbidities-An Observational Cohort Study in 825 Patients.

Authors:  Carl H Göbel; Sarah Karstedt; Axel Heinze; Britta Koch; Hartmut Göbel
Journal:  Pain Ther       Date:  2021-05-04

Review 6.  Peripheral Neuromodulation for the Management of Headache.

Authors:  Ivan Urits; Ruben Schwartz; Daniel Smoots; Lindsey Koop; Suhitha Veeravelli; Vwaire Orhurhu; Elyse M Cornett; Laxmaiah Manchikanti; Alan D Kaye; Farnad Imani; Giustino Varrassi; Omar Viswanath
Journal:  Anesth Pain Med       Date:  2020-11-30

7.  Impact of Galcanezumab on Total Pain Burden: A Post Hoc Analysis of a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study in Patients with Episodic Cluster Headache.

Authors:  J Scott Andrews; David Kudrow; Mallikarjuna Rettiganti; Tina Oakes; Jennifer N Bardos; Richard Wenzel; Dulanji K Kuruppu; Charly Gaul; James M Martinez
Journal:  J Pain Res       Date:  2021-07-08       Impact factor: 3.133

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.